Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Niewoehner

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Cancer Genomics & Proteomics|April 17, 2022
Circular RNAs With Efficacy in Preclinical <i>In Vitro</i> and <i>In Vivo</i> Models of Esophageal Squamous Cell CarcinomaUlrich H Weidle, Tatjana Sela, Ulrich Brinkmann, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentCatherine J Mummery, Roberto Villaseñor, Jens Niewoehner, et al.
Plos One|May 3, 2014
A human blood-brain barrier transcytosis assay reveals antibody transcytosis influenced by pH-dependent receptor bindingHadassah Sade, Claudia Baumgartner, Adrian Hugenmatter, et al.
Plos One|March 11, 2020
Brain Shuttle Neprilysin reduces central Amyloid-β levelsChristopher R Campos, Alicia M Kemble, Jens Niewoehner, et al.
Fluids and Barriers of the CNS|March 1, 2012
Expression and localization of claudins-3 and -12 in transformed human brain endotheliumAnja Schrade, Hadassah Sade, Pierre-Olivier Couraud, et al.
Plos One|May 14, 2013
Crystal structure of human TWEAK in complex with the Fab fragment of a neutralizing antibody reveals insights into receptor bindingAlfred Lammens, Monika Baehner, Ulrich Kohnert, et al.
Fluids and Barriers of the CNS|September 21, 2021
Investigating receptor-mediated antibody transcytosis using blood-brain barrier organoid arraysClaire Simonneau, Martina Duschmalé, Alina Gavrilov, et al.
Pharmaceutical Research|June 29, 2018
First Infusion Reactions are Mediated by FcγRIIIb and NeutrophilsFelix Weber, Daniel Breustedt, Sonja Schlicht, et al.
Communications Biology|May 15, 2025
A microfluidic bone marrow chip for the safety profiling of biologics in pre-clinical drug developmentLeopold Koenig, Laurent Juglair, Thi Phuong Tao, et al.
Cell Reports|January 4, 2018
Brain Shuttle Antibody for Alzheimer's Disease with Attenuated Peripheral Effector Function due to an Inverted Binding ModeFelix Weber, Bernd Bohrmann, Jens Niewoehner, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cancer Genomics & Proteomics|April 17, 2022
Circular RNAs With Efficacy in Preclinical <i>In Vitro</i> and <i>In Vivo</i> Models of Esophageal Squamous Cell CarcinomaUlrich H Weidle, Tatjana Sela, Ulrich Brinkmann, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentCatherine J Mummery, Roberto Villaseñor, Jens Niewoehner, et al.
Plos One|May 3, 2014
A human blood-brain barrier transcytosis assay reveals antibody transcytosis influenced by pH-dependent receptor bindingHadassah Sade, Claudia Baumgartner, Adrian Hugenmatter, et al.
Plos One|March 11, 2020
Brain Shuttle Neprilysin reduces central Amyloid-β levelsChristopher R Campos, Alicia M Kemble, Jens Niewoehner, et al.
Fluids and Barriers of the CNS|March 1, 2012
Expression and localization of claudins-3 and -12 in transformed human brain endotheliumAnja Schrade, Hadassah Sade, Pierre-Olivier Couraud, et al.
Plos One|May 14, 2013
Crystal structure of human TWEAK in complex with the Fab fragment of a neutralizing antibody reveals insights into receptor bindingAlfred Lammens, Monika Baehner, Ulrich Kohnert, et al.
Fluids and Barriers of the CNS|September 21, 2021
Investigating receptor-mediated antibody transcytosis using blood-brain barrier organoid arraysClaire Simonneau, Martina Duschmalé, Alina Gavrilov, et al.
Pharmaceutical Research|June 29, 2018
First Infusion Reactions are Mediated by FcγRIIIb and NeutrophilsFelix Weber, Daniel Breustedt, Sonja Schlicht, et al.
Communications Biology|May 15, 2025
A microfluidic bone marrow chip for the safety profiling of biologics in pre-clinical drug developmentLeopold Koenig, Laurent Juglair, Thi Phuong Tao, et al.
Cell Reports|January 4, 2018
Brain Shuttle Antibody for Alzheimer's Disease with Attenuated Peripheral Effector Function due to an Inverted Binding ModeFelix Weber, Bernd Bohrmann, Jens Niewoehner, et al.
Pageof 2